Ann: Sensera gains approval to disclose anchor customer Abiomed, page-2

Abiomed is an US$8.6b company

From prototype to commercial roll out in 12 months....

Makes you wonder how many more of these kind of companies could utilise Sensera's capabilities....

To be able to have clients like this speaks volumes about the quality of company we have in Sensera....

I still cant get over the fact how much under the radar we are, $49m M/c with forecast revenues of between US$6.25m - US$7.25m revenue for FY18.... blows BUD well out of the water imo...